USE OF INHIBITORS OF EXPRESSION OR ACTIVITY OF p8/com1 FOR TREATING TUMORS.

Details for Australian Patent Application No. 2002325345 (hide)

Owner INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

Inventors DAGORN, Jean-Charles; VASSEUR, Sophie; IOVANNA, Juan

Pub. Number AU-A-2002325345

PCT Number PCT/EP02/08058

PCT Pub. Number WO2003/004631

Priority 01401795.8 05.07.01 EP

Filing date 5 July 2002

Wipo publication date 21 January 2003

International Classifications

C12N 009/00 Enzymes, e.g. ligases (6.)

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 01401795.8 05.07.01 EP

22 May 2003 Application Open to Public Inspection

  Published as AU-A-2002325345

18 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002325346-METHOD OF ADMINISTRATION OF A GENE OF INTEREST TO THE HEART AND VASCULATURE

2002325344-Lipid blends and food products containing oleic fatty acid and omega-6 fatty acids, designed to increase the intramyocellular lilpid level